136 related articles for article (PubMed ID: 35248951)
1. Reasons for participation and non-participation in colorectal cancer screening.
Berg-Beckhoff G; Leppin A; Nielsen JB
Public Health; 2022 Apr; 205():83-89. PubMed ID: 35248951
[TBL] [Abstract][Full Text] [Related]
2. Population-based screening for colorectal cancer using an immunochemical faecal occult blood test: a comparison of two invitation strategies.
Van Roosbroeck S; Hoeck S; Van Hal G
Cancer Epidemiol; 2012 Oct; 36(5):e317-24. PubMed ID: 22560885
[TBL] [Abstract][Full Text] [Related]
3. To do or not to do - a survey study on factors associated with participating in the Danish screening program for colorectal cancer.
Nielsen JB; Berg-Beckhoff G; Leppin A
BMC Health Serv Res; 2021 Jan; 21(1):43. PubMed ID: 33413310
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening participation among citizens not recommended to be screened: a cohort study.
Larsen PT; Jørgensen SF; Njor SH
BMC Gastroenterol; 2022 May; 22(1):256. PubMed ID: 35596148
[TBL] [Abstract][Full Text] [Related]
5. Differences in diagnostic activity in general practice and findings for individuals invited to the danish screening programme for colorectal cancer: a population-based cohort study.
Juul JS; Andersen B; Laurberg S; Carlsen AH; Olesen F; Vedsted P
Scand J Prim Health Care; 2018 Sep; 36(3):281-290. PubMed ID: 29929415
[TBL] [Abstract][Full Text] [Related]
6. Low priority main reason not to participate in a colorectal cancer screening program with a faecal occult blood test.
van Rijn AF; van Rossum LG; Deutekom M; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
J Public Health (Oxf); 2008 Dec; 30(4):461-5. PubMed ID: 18716047
[TBL] [Abstract][Full Text] [Related]
7. Viewpoints of the target population regarding barriers and facilitators of colorectal cancer screening in the Czech Republic.
Kroupa R; Ondrackova M; Kovalcikova P; Dastych M; Pavlik T; Kunovsky L; Dolina J
World J Gastroenterol; 2019 Mar; 25(9):1132-1141. PubMed ID: 30863000
[TBL] [Abstract][Full Text] [Related]
8. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
9. Differential effects of colorectal cancer screening across sociodemographic groups in Denmark: a register-based study.
Pallesen AVJ; Herrstedt J; Westendorp RGJ; Mortensen LH; Kristiansen M
Acta Oncol; 2021 Mar; 60(3):323-332. PubMed ID: 33427545
[TBL] [Abstract][Full Text] [Related]
10. Are anxiety levels associated with the decision to participate in a Swedish colorectal cancer screening programme? A nationwide cross-sectional study.
Wangmar J; von Vogelsang AC; Hultcrantz R; Fritzell K; Wengström Y; Jervaeus A
BMJ Open; 2018 Dec; 8(12):e025109. PubMed ID: 30580275
[TBL] [Abstract][Full Text] [Related]
11. [The populations attitudes to colorectal cancer screening in the Czech Republic].
Král N; Seifert B; Suchánek Š; Zavoral M; Májek O
Epidemiol Mikrobiol Imunol; 2015 Mar; 64(1):41-6. PubMed ID: 25872995
[TBL] [Abstract][Full Text] [Related]
12. Uptake of a colorectal cancer screening blood test in people with elevated risk for cancer who cannot or will not complete a faecal occult blood test.
Symonds EL; Cock C; Meng R; Cole SR; Fraser RJL; Young GP
Eur J Cancer Prev; 2018 Sep; 27(5):425-432. PubMed ID: 28368949
[TBL] [Abstract][Full Text] [Related]
13. Participation in a government-subsidised colorectal cancer screening programme for asymptomatic individuals in Hong Kong.
Chan DNS; So WKW; Choi KC
Cancer Epidemiol; 2022 Aug; 79():102174. PubMed ID: 35533550
[TBL] [Abstract][Full Text] [Related]
14. Participation and yield of a population-based colorectal cancer screening programme in China.
Chen H; Li N; Ren J; Feng X; Lyu Z; Wei L; Li X; Guo L; Zheng Z; Zou S; Zhang Y; Li J; Zhang K; Chen W; Dai M; He J;
Gut; 2019 Aug; 68(8):1450-1457. PubMed ID: 30377193
[TBL] [Abstract][Full Text] [Related]
15. Would general practitioners support a population-based colorectal cancer screening programme of faecal-occult blood testing?
Tong S; Hughes K; Oldenburg B; Del Mar C
Intern Med J; 2004; 34(9-10):532-8. PubMed ID: 15482265
[TBL] [Abstract][Full Text] [Related]
16. Socio-demographic and cultural factors related to non-participation in the Dutch colorectal cancer screening programme.
van de Schootbrugge-Vandermeer HJ; Lansdorp-Vogelaar I; de Jonge L; van Vuuren AJ; Dekker E; Spaander MCW; Ramakers CRB; Nagtegaal ID; van Kemenade FJ; van Leerdam ME; Toes-Zoutendijk E
Eur J Cancer; 2023 Sep; 190():112942. PubMed ID: 37406529
[TBL] [Abstract][Full Text] [Related]
17. Motives for non-adherence to colonoscopy advice after a positive colorectal cancer screening test result: a qualitative study.
Bertels L; Lucassen P; van Asselt K; Dekker E; van Weert H; Knottnerus B
Scand J Prim Health Care; 2020 Dec; 38(4):487-498. PubMed ID: 33185121
[TBL] [Abstract][Full Text] [Related]
18. Faecal occult blood testing (FOBT)-based colorectal cancer screening trends and predictors of non-use: findings from the South Australian setting and implications for increasing FOBT uptake.
Todorov K; Wilson C; Sharplin G; Corsini N
Aust Health Rev; 2018 Feb; 42(1):45-52. PubMed ID: 28248632
[TBL] [Abstract][Full Text] [Related]
19. Participation in Competing Strategies for Colorectal Cancer Screening: A Randomized Health Services Study (PICCOLINO Study).
Pilonis ND; Bugajski M; Wieszczy P; Rupinski M; Pisera M; Pawlak E; Regula J; Kaminski MF
Gastroenterology; 2021 Mar; 160(4):1097-1105. PubMed ID: 33307024
[TBL] [Abstract][Full Text] [Related]
20. Barriers and facilitators to participate in the colorectal cancer screening programme in Flanders (Belgium): a focus group study.
Hoeck S; Van Roy K; Willems S
Acta Clin Belg; 2022 Feb; 77(1):37-44. PubMed ID: 32552612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]